Antibacterial resistance worldwide: causes, challenges and responses

Antibacterial resistance worldwide: causes, challenges and responses

30 November 2004 | Stuart B Levy & Bonnie Marshall
The article by Stuart B. Levy and Bonnie Marshall discusses the global emergence and spread of antibiotic resistance in bacteria, highlighting its increasing threat to public health. The authors trace the history of drug resistance, noting that it has been a persistent issue since the early days of antimicrobial discovery. They emphasize that resistance is not limited to a few drug-resistant strains but is widespread and affects major microbial pathogens across all regions. The review focuses on the underlying principles and ecological factors that contribute to drug resistance in bacteria, while also acknowledging the presence of resistance in other microorganisms like parasites, fungi, and viruses. The article details the evolution of resistance, from the initial emergence of resistant strains in hospitals to the widespread dissemination of multidrug-resistant (MDR) organisms. It highlights the challenges posed by MDR infections, particularly in developing countries, where poor sanitation and limited access to effective antibiotics exacerbate the problem. The authors discuss the costs associated with antibiotic resistance, including increased hospital stays, mortality, and morbidity, as well as economic burdens. The article also explores the mechanisms by which bacteria acquire and spread resistance genes, including horizontal gene transfer through mobile genetic elements such as plasmids and transposons. It explains how resistance can emerge through chromosomal mutations and the selection of resistant strains under antimicrobial pressure. The authors emphasize the importance of surveillance systems in tracking resistance patterns and the need for prudent antibiotic use to prevent the further spread of resistance. Finally, the article outlines strategies for managing and preventing drug resistance, including the development of new antibiotics, rapid diagnostics, and the use of conjugated vaccines. It concludes with a call to action, urging a broader perspective on resistance as an ecological problem and the need to preserve existing antimicrobials while intensifying efforts to discover new therapeutics.The article by Stuart B. Levy and Bonnie Marshall discusses the global emergence and spread of antibiotic resistance in bacteria, highlighting its increasing threat to public health. The authors trace the history of drug resistance, noting that it has been a persistent issue since the early days of antimicrobial discovery. They emphasize that resistance is not limited to a few drug-resistant strains but is widespread and affects major microbial pathogens across all regions. The review focuses on the underlying principles and ecological factors that contribute to drug resistance in bacteria, while also acknowledging the presence of resistance in other microorganisms like parasites, fungi, and viruses. The article details the evolution of resistance, from the initial emergence of resistant strains in hospitals to the widespread dissemination of multidrug-resistant (MDR) organisms. It highlights the challenges posed by MDR infections, particularly in developing countries, where poor sanitation and limited access to effective antibiotics exacerbate the problem. The authors discuss the costs associated with antibiotic resistance, including increased hospital stays, mortality, and morbidity, as well as economic burdens. The article also explores the mechanisms by which bacteria acquire and spread resistance genes, including horizontal gene transfer through mobile genetic elements such as plasmids and transposons. It explains how resistance can emerge through chromosomal mutations and the selection of resistant strains under antimicrobial pressure. The authors emphasize the importance of surveillance systems in tracking resistance patterns and the need for prudent antibiotic use to prevent the further spread of resistance. Finally, the article outlines strategies for managing and preventing drug resistance, including the development of new antibiotics, rapid diagnostics, and the use of conjugated vaccines. It concludes with a call to action, urging a broader perspective on resistance as an ecological problem and the need to preserve existing antimicrobials while intensifying efforts to discover new therapeutics.
Reach us at info@study.space